Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Markj Gilbert News

Markj Gilbert News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Markj Gilbert. Real-time updates on events, politics, business and more.

JW Therapeutics: Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress

May 30, 2024
SHANGHAI, May 30, 2024 /PRNewswire/ -- JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology
Hong Kong Markj Gilbert A Bristol Myers Squibb Ltd The Company Prnewswire Jw Cayman Therapeutics Co China National Medical Products Administration
Source: finanznachrichten.de

JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva(R) in Patients with Relapsed or Refractory Mantle Cell Lymphoma

January 5, 2024
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) of China
Markj Gilbert Chinj Hematol China National Medical Products Administration Bristol Myers Squibb National Medical Products Administration National Significant New Drug Development Program
Source: newswit.com

2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies

September 12, 2023
Initial MAGE-A4 T-cell collaboration program set to enter clinic ahead of schedule by end of 2023 Companies plan to add programs in oncology and autoimmune disease to collaboration ...
Hong Kong Markj Gilbert Steve Bernstein Exchange Commission Clearing Limited Chief Medical Officer
Source: marketscreener.com

JW Therapeutics Presents Primary Clinical Response on Carteyva® (relmacabtagene autoleucel injection) in Adults with Relapsed/Refractory Follicular Lymphoma in China at the 63rd ASH Annual Meeting

December 15, 2021
/PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell...
United States Hong Kong Markj Gilbert A Bristol Myers Squibb American Society Of Hematology National Significant New Drug Development Program
Source: prnewswire.com

JW Therapeutics Presents Primary Clinical Response on Carteyva® (relmacabtagene autoleucel injection) in Adults with Relapsed/Refractory Follicular Lymphoma in China at the 63rd ASH Annual Meeting

December 15, 2021
/PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell...
United States Hong Kong Markj Gilbert A Bristol Myers Squibb American Society Of Hematology National Significant New Drug Development Program
Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science